These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23002724)

  • 1. μ-Opioid receptor desensitization: homologous or heterologous?
    Llorente J; Lowe JD; Sanderson HS; Tsisanova E; Kelly E; Henderson G; Bailey CP
    Eur J Neurosci; 2012 Dec; 36(12):3636-42. PubMed ID: 23002724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
    Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
    Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons.
    Dang VC; Chieng BC; Christie MJ
    Mol Pharmacol; 2012 Sep; 82(3):473-80. PubMed ID: 22689562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
    Li AH; Wang HL
    J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons.
    Bailey CP; Oldfield S; Llorente J; Caunt CJ; Teschemacher AG; Roberts L; McArdle CA; Smith FL; Dewey WL; Kelly E; Henderson G
    Br J Pharmacol; 2009 Sep; 158(1):157-64. PubMed ID: 19309357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
    Blanchet C; Sollini M; Lüscher C
    Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.
    Bailey CP; Llorente J; Gabra BH; Smith FL; Dewey WL; Kelly E; Henderson G
    Eur J Neurosci; 2009 Jan; 29(2):307-18. PubMed ID: 19200236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons.
    Llorente J; Withey S; Rivero G; Cunningham M; Cooke A; Saxena K; McPherson J; Oldfield S; Dewey WL; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2013 Aug; 84(2):252-60. PubMed ID: 23716621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions.
    Tan M; Groszer M; Tan AM; Pandya A; Liu X; Xie CW
    J Neurosci; 2003 Nov; 23(32):10292-301. PubMed ID: 14614088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of orexin (hypocretin) on GIRK channels.
    Hoang QV; Bajic D; Yanagisawa M; Nakajima S; Nakajima Y
    J Neurophysiol; 2003 Aug; 90(2):693-702. PubMed ID: 12702704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endomorphin-2: a biased agonist at the μ-opioid receptor.
    Rivero G; Llorente J; McPherson J; Cooke A; Mundell SJ; McArdle CA; Rosethorne EM; Charlton SJ; Krasel C; Bailey CP; Henderson G; Kelly E
    Mol Pharmacol; 2012 Aug; 82(2):178-88. PubMed ID: 22553358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
    Jongeling AC; Johns ME; Murphy AZ; Hammond DL
    Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization.
    Wang HL
    Neuropharmacology; 2000 Jan; 39(3):353-63. PubMed ID: 10698001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.
    Hull LC; Llorente J; Gabra BH; Smith FL; Kelly E; Bailey C; Henderson G; Dewey WL
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1127-35. PubMed ID: 20008489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
    Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
    J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of mu-opioid receptor-evoked potassium currents: initiation at the receptor, expression at the effector.
    Blanchet C; Lüscher C
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4674-9. PubMed ID: 11917119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Phosphorylation Sites in Desensitization of µ-Opioid Receptor.
    Yousuf A; Miess E; Sianati S; Du YP; Schulz S; Christie MJ
    Mol Pharmacol; 2015 Oct; 88(4):825-35. PubMed ID: 25969388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.
    Moulédous L; Froment C; Dauvillier S; Burlet-Schiltz O; Zajac JM; Mollereau C
    J Biol Chem; 2012 Apr; 287(16):12736-49. PubMed ID: 22375000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.